| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
03-10-2015, 08:04 AM
|
#1 | ||
|
|||
|
Magnate
|
like insulin pump, they expect to be approved by 2018? doesn't require surgery like duodopa, alternative to DBS
http://www.wsw.com/webcast/roth29/ndrm/ if you can't get to it from this link, try this link http://www.roth.com/main/page.aspx?PageID=7209 then select webcasts sorry about the investment hype in the webcast but they say their treatment greatly reduces dyskinesia and OFF times and is a 24hr treatment. but expensive! |
||
|
 Reply With Quote
|
| "Thanks for this!" says: |
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| l-dopa pump - NeuroDerm signs definitive investment agreements for $16 million financ | Parkinson's Disease | |||
| NeuroDerm Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 In | Parkinson's Disease | |||
| patch pump for carbidopa/l-dopa might work but years away | Parkinson's Disease | |||
| neurologix investor presentation | Parkinson's Disease | |||
| PD research - investor's viewpoint | Parkinson's Disease | |||
investor presentation by NeuroDerm Ltd., developing l-dopa pump
Linear Mode
